Literature DB >> 6787828

C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma.

M Chupin, B Charbonnel, F Chupin.   

Abstract

For further evaluation of B-cell secretion in diabetic keto-acidosis (KA) and in non-ketotic hyperosmolar coma (NKHC), basal and post-i.v. tolbutamide blood CPR and IRI values were measured in 34 patients (22 KA and 12 NKHC). FFA, cortisol and HGH measurements were also performed. IRI was low in both KA and NKHC (0.07 +/- 0.01 and 0.082 +/- 0.01 nmol/l) as opposed to CPR which was significantly higher in NKHC (1.14 +/- 0.1 nmol/l) than in KA (0.21 +/- 0.03 nmol/l). After tolbutamide injection, CPR and IRI levels did not change in any of the KA cases, whereas they significantly increased in half of the NKHC cases. Cortisol and FFA values were similarly increased in both situations, as opposed to HGH which was significantly higher (6.1 +/- 1.2 ng/ml) in KA than in NKHC (1.9 +/- 0.2 ng/ml). These results suggest that B-cell function is less deficient in NKHC than in KA. Residual insulin amounts reaching the liver via the portal vein could partly account for the absence of ketosis in NKHC.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787828     DOI: 10.1007/BF02098997

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  21 in total

1.  A radioimmunoassay for cortisol in plasma and urine.

Authors:  H J Ruder; R L Guy; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

2.  Lilly Lecture 1978. New perspectives in the regulation of ketogenesis.

Authors:  J D McGarry
Journal:  Diabetes       Date:  1979-05       Impact factor: 9.461

3.  Metabolic findings in hyperosmolar, non-ketotic diabetic stupor.

Authors:  A Vinik; H Seftel; B I Joffe
Journal:  Lancet       Date:  1970-10-17       Impact factor: 79.321

4.  Insulin radioimmunoassay: a comparison of three methods.

Authors:  R Malvano; G C Zucchelli; T Quesada; C Gandolfi; M A Piro
Journal:  J Nucl Biol Med       Date:  1974-04

5.  Mechanisms and management of hyperosmolar coma without ketoacidosis in the diabetic.

Authors:  R D Johnson; J W Conn; C J Dykman; S Pek; J I Starr
Journal:  Diabetes       Date:  1969-02       Impact factor: 9.461

6.  Plasma insulin and growth hormone levels in obesity and diabetes.

Authors:  R S Yalow; S M Glick; J Roth; S A Berson
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

7.  Pathogenesis of nonketotic hyperosmolar diabetic coma.

Authors:  B I Joffe; R B Goldberg; L H Krut; H C Seftel
Journal:  Lancet       Date:  1975-05-10       Impact factor: 79.321

8.  C-peptide metabolism and the liver.

Authors:  C Kühl; O K Faber; P Hornnes; S L Jensen
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

9.  [Hormone and metabolic profile in diabetic hyperosomolar coma. Plasma insulin response to intravenous tolbutamide (author's transl)].

Authors:  M Chupin; B Charbonnel; B Dubin; J P Remi; J Guillon
Journal:  Diabete Metab       Date:  1978-12

10.  Hormonal regulation of ketone-body metabolism in man.

Authors:  K G Alberti; D G Johnston; A Gill; A J Barnes; H Orskov
Journal:  Biochem Soc Symp       Date:  1978
View more
  4 in total

Review 1.  Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment.

Authors:  Francisco J Pasquel; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2014-11       Impact factor: 19.112

Review 2.  Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.

Authors:  Maya Fayfman; Francisco J Pasquel; Guillermo E Umpierrez
Journal:  Med Clin North Am       Date:  2017-05       Impact factor: 5.456

Review 3.  Hyperglycaemic crises and lactic acidosis in diabetes mellitus.

Authors:  P English; G Williams
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

4.  The potential effect of metabolic alkalosis on insulin sensitivity in an adolescent with new-onset type 1 diabetes.

Authors:  William E Novotny; Irma Fiordalisi; Cynthia P Keel; Glenn D Harris
Journal:  Clin Case Rep       Date:  2021-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.